Jonas Göran Ekblom

President & Chief Executive Officer at Promore Pharma AB

Jonas Göran Ekblom

Jonas Göran Ekblom

President & Chief Executive Officer at Promore Pharma AB

Overview
Career Highlights

Nanostream, Inc.
Pergamum AB
Promore Pharma AB

RelSci Relationships

278

Number of Boards

6

Birthday

1965

Age

55
Contact Data
Trying to get in touch with Jonas Göran Ekblom? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
View Relationship Details
RelSci Relationships are individuals Jonas Göran Ekblom likely has professional access to. A relationship does not necessarily indicate a personal connection.
Martin Nicklasson

Founder at Nicklasson Life Science AB

Relationship likelihood: Strong

Göran Harald Linder

Managing Director at Midroc New Technology AB

Relationship likelihood: Strong

Jan Nilsson

Chief Executive Officer & Director at Combigene AB

Relationship likelihood: Strong

Nils-Göran Pettersson

Vice Chairman at Mobidiag Oy

Relationship likelihood: Strong

Torsten Rüdiger Goesch

Partner at Rosetta Capital Ltd.

Relationship likelihood: Strong

Margit Mahlapuu

Chief Executive Officer at Scandicure AB

Relationship likelihood: Strong

Gustav Ingemar Kihlström

Associate Professor at University of Uppsala

Relationship likelihood: Strong

Ulrika Maria Wennberg

Accountant at Södertörns Energi AB

Relationship likelihood: Strong

Ronan Brown

Former Professional at BRI International, Inc.

Relationship likelihood: Strong

Yvonne Gunsch-Wegmann

Former Chief Financial Officer & Director at EffRx Pharmaceuticals SA

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
ENP Newswire
November 23, 2020
-Invitation to Conference Call regarding Promore Pharma's Interim Report for the Third Quarter 2020
ENP Newswire
October 28, 2020
-Nomination Committee Appointed for the Annual General Meeting 2021 in Promore Pharma
ENP Newswire
August 26, 2020
-Promore Pharma - Promore Pharma AB (publ) Interim report January, June 2020
ENP Newswire
August 20, 2020
-Invitation to Presentation of Promore Pharma's Interim Report for the Second Quarter 2020
ENP Newswire
July 15, 2020
-Promore Pharma is granted a Patent for ropocamptide in the US
Trending People
Gretchen Whitmer
Statehouses Brace For Potential Violence As Biden's Inauguration Approaches - npr.org
Angela Merkel
Germany: Merkel's party elects pragmatic Laschet as leader - St. Paul Pioneer Press (Minnesota)
Boris Johnson
Brexit: How travel to the EU has changed - The Independent UK
Kamala D. Harris
INAUGURATION EXPLAINER: Biden's event will be very different - The Canadian Press
Alex Ferguson
Rejuvenated Red Devils ready to rumble in Liverpool; Their erratic form aside, t... - The Business Times Singapore
Trending People
Gretchen Whitmer
Statehouses Brace For Potential Violence As Biden's Inauguration Approaches - npr.org
Angela Merkel
Germany: Merkel's party elects pragmatic Laschet as leader - St. Paul Pioneer Press (Minnesota)
Boris Johnson
Brexit: How travel to the EU has changed - The Independent UK
Kamala D. Harris
INAUGURATION EXPLAINER: Biden's event will be very different - The Canadian Press
Alex Ferguson
Rejuvenated Red Devils ready to rumble in Liverpool; Their erratic form aside, t... - The Business Times Singapore
Paths to Jonas Göran Ekblom
Potential Connections via
Relationship Science
You
Jonas Göran Ekblom
President & Chief Executive Officer at Promore Pharma AB
Education
Stockholm University

Stockholm University is a state university in Stockholm, Sweden. Stockholm University has two scientific fields: the natural sciences and the humanities/social sciences. It has over 66,000 students at four different faculties: law, humanities, the mathematical and natural sciences making it one of the largest universities in Scandinavia. The institution is also frequently regarded as one of the top 200 universities in the world.

University of Uppsala

Uppsala Universty is a world class research and educational institution in Sweden.

Career History
Chief Executive Officer
2010 - Current
Pergamum AB

Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden.

President & Chief Executive Officer
2010 - Current
Promore Pharma AB

Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. Its projects include PXL01 and LL-37. The PXL01 project will be used for prevention of post-surgical adhesions and scars is being prepared for clinical Phase III-studies in patients undergoing tendon repair surgery in the hand. The LL-37 project will used to prepare for a clinical Phase IIb study in patients with venous leg ulcers. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden.

Associate Professor
Current
University of Uppsala

Uppsala Universty is a world class research and educational institution in Sweden.

Boards & Committees
Director
Prior - 2012
Anaborex, Inc.

Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA
Investments
Details Hidden
Anaborex, Inc.

Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA

Other Affiliations

Jonas Göran Ekblom is affiliated with Pergamum AB, Promore Pharma AB, University of Uppsala, Anaborex, Inc., Nanostream, Inc., BOWS Pharmaceuticals AG, Biovitrum AB, Pharmacia AB, Invitrogen AB, Sequenom GmbH, Anaborex, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jonas Göran Ekblom. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jonas Göran Ekblom's profile does not indicate a business or promotional relationship of any kind between RelSci and Jonas Göran Ekblom.